Guardant Health (GH) Inventory (2017 - 2026)

Guardant Health has reported Inventory for 10 years, with the latest figure at $105.5 million in Q2 2026.

• Quarterly Inventory rose 25.46% year-over-year to $105.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $105.5 million (up 25.46% YoY) and the FY2025 annual result came in at $85.9 million, up 20.81% from the prior year.
• Inventory advanced to $105.5 million in Q2 2026 per GH's latest filing, from $83.9 million in the prior quarter.
• Over five years, Inventory peaked at $105.5 million in Q2 2026 and troughed at $36.6 million in Q1 2022.
• A 5-year average of $69.9 million and a median of $69.0 million in 2024 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2024: Inventory soared 154.85% in 2022, then decreased 6.15% in 2024.
• Over 5 years, Inventory stood at $51.6 million in 2022, then climbed by 20.06% to $61.9 million in 2023, then increased by 14.75% to $71.1 million in 2024, then increased by 20.81% to $85.9 million in 2025, then increased by 22.81% to $105.5 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $105.5 million, $83.9 million, and $85.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.